Announcement

Collapse
No announcement yet.

Welcome to our forum! Before posting your questions, please read the following terms:

  1. 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
  2. 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
  3. 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
  4. 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.

By posting to the forums, you acknowledge and agree to these terms.

The InfantRisk team

How long after finishing Paxlovid is it safe to breastfeed?

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • How long after finishing Paxlovid is it safe to breastfeed?

    Dear InfantRisk,

    I am finding conflicting information on when to resume breastfeeding my ten-months old baby after taking the last dose of Paxlovid. Could you please help me with what you think is the most reasonable waiting time based on your (and any available) research? Thank you, maya

  • #2
    I don't think you really need to wait much at all. We have many women who are using this drug and simultaneously breastfeeding. We've not received any indication of problems for the infant.

    At present there is no data on the transfer of Paxlovid combination product into human milk. Nirmatrelvir probably transfers into milk but we do not think it would be a problem in an infant.
    Due to modest protein binding and molecular weight, nirmatrelvir is only expected to transfer into milk to a moderate degree. A transient small decrease in body weight (<10%) was observed in the nursing offspring of rats administered nirmatrelvir at doses 8 times higher than human equivalents. While it is not ideal for a breastfeeding mother, it is likely the benefit of treatment against COVID-19 may outweigh the infant risk of drug transfer with a short duration of therapy. Ritonavir is used to boost concentrations of nirmatrelvir. Ritonavir has been studied in breastfeeding mothers. It has moderate transfer into milk and low serum concentrations in some infants, but no reported adverse effects. Please refer to the ritonavir monograph for detailed information.

    Tom Hale

    Comment


    • #3
      Dear Dr Hale,

      Thank you so much for your response. You helped me make the decision to continue to breastfeed my baby after I was considering moving to formula completely. This website is an amazing research-based resource for nursing moms!

      Thanks again,
      maya

      Comment

      Working...
      X